closerlook, inc. to deliver an in-depth presentation on how to leverage eDetailing as a strategic listening post

Chicago, IL - August 17, 2006 - David Ormesher, CEO, closerlook, inc., and Darren Ostmeyer, Senior Product Manager of Neuroscience Marketing, Takeda Pharmaceuticals North America, to present at CBI's 5th Annual eDetailing Conference.

closerlook is pleased to announce that David Ormesher, CEO, closerlook, inc. and Darren Ostmeyer, Senior Product Manager of Neuroscience Marketing, Takeda Pharmaceuticals North America, will make an in-depth presentation entitled "Completing the Relationship—Leveraging eDetailing as a Strategic Listening Post" at the 5th Annual eDetailing conference, a showcase for next-generation solutions that enable companies to revitalize physician relationships and best convey product information. Ormesher and Ostmeyer will draw on their expertise in creating strategic, interactive marketing pieces for the healthcare industry to present their shared vision of eDetailing as a valuable two-way communication between doctor and pharmaceutical company.

The Center for Business Intelligence will host the 5th Annual Summit on eDetailing from September 28-29, 2006 at the Hilton Philadelphia City Avenue in Philadelphia, PA.

"Darren and I are excited to attend and participate in the CBI eDetailing conference," Ormesher said. "We feel that eDetailing still has untapped potential as a sales and information-gathering tool, and we're looking forward to presenting strategies for fulfilling that potential."

"When companies think of eDetailing as a one-way promotional tactic, they miss an opportunity to build a relationship and learn more about what makes doctors write," Takeda's Ostmeyer said. "Dave and I will discuss some of the ways we're making eDetailing a two-way street."

Speakers from Manhattan Research, Digene Corporation, HyGro Consulting Group, Sanofi Aventis, Pharma Marketing News, Novartis and other organizations will join Ormesher and Ostmeyer in providing industry perspectives and case studies at the conference.

In its 5th year, CBI's eDetailing Conference will feature detailed case studies from some of the industry's leading organizations, and provide attendees with the information needed to improve technology-supported detailing and increase ROI. Key topics to be discussed at the conference include eDetailing technologies and regulations and overcoming the challenges of expanding sales forces and limited physician time.

For more information on the 5th Annual eDetailing conference, or to register, contact CBI Registration at 800-817-8601, or via email at cbireg@cbinet.com.

About closerlook, inc.
closerlook, inc. is a strategic communications agency focused on getting its clients closer to their customers. Since 1987, closerlook has collaborated with its clients to create innovative marketing and communication programs that enhance their ability to connect with their best customers - both internal and external - to deliver business results. To enable pharmaceutical companies to more effectively develop long-term, profitable relationships with their target physicians, closerlook developed its enterprise-level Physician Relationship Management platform. Since 2000, closerlook has been creating and managing private-label, pharma-branded Integrated eDetailing^TM programs for leading pharmaceutical brands, delivering strong ROI, unique physician insight, and lasting relationships with healthcare professionals.

The company's corporate headquarters are located in downtown Chicago. Additional information on closerlook can be found at http://www.closerlook.com.

About Takeda Pharmaceuticals North America, Inc.
Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc., is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda currently markets oral diabetes, insomnia, cholesterol-lowering and gastroenterology treatments, and through the Takeda Global Research & Development Center, Inc., the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about the company and its products, visit http://www.tpna.com.

About the Center for Business Intelligence:
CBI is a world-class conference company that focuses on producing high-level programs for executive decision-makers who face strategic issues in domestic and international markets. CBI's Pharmaceutical and Biotech Division produces some of the most innovative and "must attend" events for the pharmaceutical and biotech industries. Visit: www.cbinet.com for more information.